Skip to main content
Michael Presti, MD, Neurology, Lenox, MA, Community Hospital of the Monterey Peninsula

MichaelFranzPrestiMDPhD

Neurology Lenox, MA

Pain Medicine, Sleep Medicine

CEO, SafeRX Pharmaceuticals Inc.

Dr. Presti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Presti's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Sleep Medicine, 2012 - 2013
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2009 - 2012
  • University of Maryland Medical Center Midtown Campus
    University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 2008 - 2009
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 2008

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - 2026
  • MA State Medical License
    MA State Medical License 2022 - 2024
  • NY State Medical License
    NY State Medical License 2021 - 2023
  • CA State Medical License
    CA State Medical License 2019 - 2023
  • OR State Medical License
    OR State Medical License 2014 - 2021
  • MN State Medical License
    MN State Medical License 2009 - 2014
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Sleep Medicine

Publications & Presentations

PubMed

Journal Articles

  • Degeneration of brainstem respiratory neurons in dementia with Lewy bodies  
    Presti MF; Schmeichel MA; Low PA; Parisi JE; Benarroch EE, Sleep, 2/2014

Authored Content

  • Fix Roof, Not Tarp in Battle Against Opioid CrisisMay 2021

Press Mentions

  • SafeRX Pharmaceuticals to Exhibit Alcohol-Resistant Opioid Platform at 2021 FSIPP/FSPMR Annual Conference
    SafeRX Pharmaceuticals to Exhibit Alcohol-Resistant Opioid Platform at 2021 FSIPP/FSPMR Annual ConferenceJuly 26th, 2021

Professional Memberships

Hospital Affiliations